Cargando…
A Pharmacist-Led Oral Chemotherapy Program's Impact on Chronic Myeloid Leukemia Patient Satisfaction, Adherence, and Outcomes
Patients with chronic myeloid leukemia (CML) can be treated with oral tyrosine kinase inhibitors (TKIs). Pharmacist-led oral chemotherapy programs (POCPs) can improve TKI adherence rates, but evaluation of patient satisfaction with such programs is rare. The purpose of this analysis was to compare t...
Autores principales: | Dennison, Taylor, Deal, Allison M., Foster, Matthew, Valgus, John, Muluneh, Benyam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017794/ https://www.ncbi.nlm.nih.gov/pubmed/34109047 http://dx.doi.org/10.6004/jadpro.2021.12.2.3 |
Ejemplares similares
-
Impact of Adherence to Ibrutinib on Clinical Outcomes in Real-World Patients With Chronic Lymphocytic Leukemia
por: Garner, Lauren M., et al.
Publicado: (2021) -
Understanding Barriers to Oral Therapy Adherence in Adults With Acute Myeloid Leukemia
por: Bryant, Ashley Leak, et al.
Publicado: (2020) -
Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics
por: Palmer, Shannon, et al.
Publicado: (2021) -
Research Strategy for the Development of a Quality-of-Life Decision-Making Model for Older Patients With Acute Myeloid Leukemia
por: Tinsley-vance, Sara M.
Publicado: (2023) -
Evaluation of the Role and Impact of Ambulatory Clinical Pharmacists in an Academic Comprehensive Cancer Center
por: Meleis, Laura A., et al.
Publicado: (2020)